FAS Statement on Michael Kratsios’ OSTP Hearing
Yesterday, Michael Kratsios, the president’s nominee to be director of the White House Office of Science and Technology Policy (OSTP), repeatedly stressed his belief in the importance of continuing the United States’ historic leadership in science and technological innovation, and the goal of “ensuring that all Americans benefit from scientific and technological advances.”
Mr. Kratsios’ words, along with his track record and OSTP experience as U.S. Chief Technology Officer, offer encouragement that our community can continue to work constructively with him and the important office he would lead.
With so much at stake, we cannot afford to cede science and technological leadership or its underpinnings: foundational federal R&D investments, growing STEM talent pipelines, and the best scientific and technical expertise to support policymakers. Commitment to these things are the basis for a healthy and thriving society.
As humans expand our geographic reach, encroach on untouched natural territories, and interact more with animal populations, we will encounter novel zoonotic diseases that threaten the human body. The sooner we act to address these risks, the better.
This report serves as a landscape assessment and toolbox from which local governments can negotiate an informed position when it comes to the levers available to them and includes a first-of-its kind analysis of eight executed community benefits agreements.
When a hurricane hits, it’s all hands on deck – that goes for federal data, too. Pulling back from our investments in timely, accurate, and accessible public data will only make us less prepared and put us all at greater risk.
This is bigger than a singular elimination of race and ethnicity questions. It could accelerate the second wave of widespread reductions to demographic data, leaving public health officials with even less information to deliver better health outcomes for all Americans.